{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:46:26Z","timestamp":1787942786770,"version":"build-2784847793"},"reference-count":24,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Antibiotic therapy is essential for managing bacterial infections, but rare yet serious hematological complications such as leukopenia and agranulocytosis may occur. These conditions, although uncommon, require timely diagnosis and intervention, particularly in vulnerable populations such as postpartum patients. This case report describes a 31-year-old puerperal woman who developed agranulocytosis after extended antibiotic treatment for a presumed multidrug-resistant infection. Initially treated with ceftriaxone and metronidazole, her therapy was later escalated to include ciprofloxacin, amoxicillin\u2013clavulanic acid, and vancomycin. Enterococcus spp. and Staphylococcus aureus were isolated from multiple sites, although no systemic infection was confirmed. Bone marrow findings were consistent with agranulocytosis in the recovery phase. Despite improvements in infection markers, her leukocyte count progressively declined, reaching a nadir of 1.61 \u00d7 109\/L on the 19th day of therapy. Granulocyte-colony stimulating factor (G-CSF) therapy was initiated, resulting in hematological recovery. The patient was discharged with normal inflammatory markers and leukocyte counts. This case highlights the importance of diagnostic precision, rational antibiotic use, and timely hematologic assessment during prolonged antimicrobial treatment.<\/jats:p>","DOI":"10.3390\/ijms26146584","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T12:46:33Z","timestamp":1752237993000},"page":"6584","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Puerperal Patient with Leukopenia During Vancomycin Administration: A Case Report and Review of the Literature"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-0707","authenticated-orcid":false,"given":"Lidija","family":"Tulic","sequence":"first","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9176-9736","authenticated-orcid":false,"given":"Katarina","family":"Ivanovic","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Tulic","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5874-9725","authenticated-orcid":false,"given":"Svetlana","family":"Vrzic-Petronijevic","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Ivanovic","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Clinic \u201cNarodni Front\u201d, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Bratic","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4957-4729","authenticated-orcid":false,"given":"Milo\u0161","family":"Petronijevic","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Center of Serbia, 11 000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-7125(05)70309-6","article-title":"Antibiotic side effects","volume":"85","author":"Cunha","year":"2001","journal-title":"Med. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/QCO.0000000000000932","article-title":"Neutropenia and antibiotics: When, what, how and why?","volume":"36","author":"Dickter","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOH.0000000000000208","article-title":"How I diagnose and treat neutropenia","volume":"23","author":"Dale","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: Agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1098-3597(06)80053-0","article-title":"Neutropenia: Etiology and pathogenesis","volume":"8","author":"Schwartzberg","year":"2006","journal-title":"Clin. Cornerstone"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.12659\/AJCR.909956","article-title":"Agranulocytosis Induced by Vancomycin: Case Report and Literature Review","volume":"19","author":"Castroagudin","year":"2018","journal-title":"Am. J. Case Rep."},{"key":"ref_7","first-page":"218","article-title":"Comprehensive Analysis of Antibiotic-Induced Agranulocytosis Using the Japanese Adverse Drug Event Report Database","volume":"74","author":"Asai","year":"2021","journal-title":"Jpn. J. Antibiot."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ajh.21433","article-title":"Idiosyncratic drug-induced agranulocytosis: Possible mechanisms and management","volume":"84","author":"Tesfa","year":"2009","journal-title":"Am. J. Hematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1177\/1060028020975646","article-title":"A Review of \u03b2-Lactam-Associated Neutropenia and Implications for Cross-reactivity","volume":"55","author":"Cimino","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"ref_10","unstructured":"Sedhai, Y.R., Lamichhane, A., and Gupta, V. (2025). Agranulocytosis. 2023 May 23. StatPearls, StatPearls Publishing."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1345\/aph.1E187","article-title":"Probable vancomycin-induced neutropenia","volume":"38","author":"Tagoff","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2152\/jmi.68.368","article-title":"A puerperal patient with agranulocytosis during tazobactam\/piperacillin administration: A case report","volume":"68","author":"Iwazawa","year":"2021","journal-title":"J. Med. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e0159622","DOI":"10.1128\/aac.01596-22","article-title":"Antibiotic-induced neutropenia in patients receiving outpatient parenteral antibiotic therapy: A retrospective cohort study","volume":"67","author":"Lam","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","first-page":"508","article-title":"Granulocyte colony-stimulating factor in the treatment of drug-induced agranulocytosis: Experience and recommendations","volume":"251","author":"Holz","year":"2002","journal-title":"J. Intern. Med."},{"key":"ref_15","first-page":"353","article-title":"Meropenem-induced neutropenia in a neonate","volume":"21","author":"Jones","year":"2016","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/postgradmedj-2020-139415","article-title":"Amoxicillin\/clavulanic acid-associated severe neutropenia","volume":"98","author":"Schattner","year":"2022","journal-title":"Postgrad. Med. J."},{"key":"ref_17","first-page":"6","article-title":"Severe neutropenia during treatment with amoxicillin\/clavulanic acid in a patient on regular hemodialysis treatment","volume":"33","author":"Spetrino","year":"2016","journal-title":"G. Ital. Nefrol."},{"key":"ref_18","first-page":"5718716","article-title":"Amoxicillin\/Clavulanic Acid-Induced Agranulocytosis: A Case Report and Review of the Literature","volume":"2019","author":"Villalba","year":"2019","journal-title":"Case Rep. Hematol."},{"key":"ref_19","first-page":"002215","article-title":"Ceftriaxone-induced agranulocytosis","volume":"8","author":"Couto","year":"2021","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_20","first-page":"004593","article-title":"Neutropenia induced by ceftriaxone and meropenem","volume":"11","author":"Aung","year":"2024","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-93-4-585","article-title":"Metronidazole","volume":"93","author":"Finegold","year":"1980","journal-title":"Ann. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/bmj.2.6199.1219-a","article-title":"Neutropenia associated with metronidazole","volume":"2","author":"Bergan","year":"1979","journal-title":"Br. Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/asheducation-2017.1.187","article-title":"Non-chemotherapy drug-induced neutropenia: Key points to manage the risk","volume":"2017","author":"Curtis","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO Clinical Practice Guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann. Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/14\/6584\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:07:08Z","timestamp":1760033228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/14\/6584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":24,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26146584"],"URL":"https:\/\/doi.org\/10.3390\/ijms26146584","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}